A

AVROBIO

89 employees

Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Genetics
Gene Therapy and Rare Disease

Date founded

2015

Funding rounds raised

Total raised

$60M

from 11 investors over 11 rounds

A

AVROBIO raised $60M on February 1, 2018

Investors: Leerink Partners LLC, Research Division, Aisling Capital, Atlas Venture, SV Life Sciences, Clarus Ventures, LLC, Brace Pharma Capital and Morningside Venture Partners

A

AVROBIO raised $25M on August 2, 2016

Investors: Atlas Venture, SV Life Sciences and Clarus Ventures, LLC

A

AVROBIO raised undisclosed on February 18, 2016

Investors: Atlas Venture

FAQ